#1 Clinical Trials Search in Europe

Lauromacrogol 400

Lauromacrogol 400, also known as polidocanol, is a medication being studied in various clinical trials for its potential in treating vascular and gastrointestinal conditions. These trials aim to evaluate its effectiveness and safety in addressing issues such as venous insufficiency, hemorrhoids, and gastric varices. The studies explore different formulations and applications of Lauromacrogol 400, comparing it to other treatments and assessing its impact on patient outcomes.

Table of Contents

What is Lauromacrogol 400?

Lauromacrogol 400, also known as polidocanol, is a medical compound used in various treatments, primarily for vascular conditions. It belongs to a class of drugs called sclerosing agents, which means it can cause controlled damage to blood vessels, leading to their closure[1]. This property makes it useful in treating conditions where problematic blood vessels need to be eliminated.

Medical Uses of Lauromacrogol 400

Lauromacrogol 400 is used to treat several medical conditions, including:

  • Venous insufficiency: A condition where veins have trouble sending blood from the legs back to the heart[1]
  • Hemorrhoids: Swollen veins in the lower rectum and anus[2]
  • Gastric varices: Enlarged veins in the stomach, often due to liver disease[3]

Treatment of Venous Insufficiency

For venous insufficiency, Lauromacrogol 400 is used in a procedure called sclerotherapy. In this treatment, the drug is injected into problematic veins, causing them to close and eventually be reabsorbed by the body. This helps improve blood flow and reduce symptoms like leg pain and swelling[1].

Research is ongoing to determine the most effective concentration of Lauromacrogol 400 for treating venous insufficiency. One study is comparing 3% versus 1% concentrations to evaluate their efficacy and tolerance[1].

Treatment of Hemorrhoids

Lauromacrogol 400 is also used to treat internal hemorrhoids. In this application, it’s used in a procedure called endoscopic foam sclerotherapy. The drug is turned into a foam and injected into the hemorrhoids using a special instrument (endoscope) that allows the doctor to see inside the rectum[2].

This treatment aims to reduce bleeding, itching, and the size of the hemorrhoids. Researchers are studying whether the foam version of Lauromacrogol 400 is more effective than the liquid version for treating hemorrhoids[2].

Treatment of Gastric Varices

Gastric varices are enlarged veins in the stomach that can occur in people with liver disease. These veins can bleed, causing serious complications. Lauromacrogol 400 is being studied as a treatment for gastric varices, often in combination with other substances[3].

In some studies, Lauromacrogol 400 is mixed with a substance called cyanoacrylate (a type of medical glue) and injected into the enlarged veins. This combination is being compared to other treatments to see which is most effective at preventing bleeding from gastric varices[3][4][5][6].

How is Lauromacrogol 400 Administered?

Lauromacrogol 400 is typically administered by a healthcare professional. The method of administration depends on the condition being treated:

  • For venous insufficiency: It’s injected directly into the problematic veins, often guided by ultrasound[1].
  • For hemorrhoids: It’s administered as a foam through an endoscope (a thin, flexible tube with a camera)[2].
  • For gastric varices: It’s often mixed with other substances and injected into the enlarged veins in the stomach during an endoscopic procedure[3].

Ongoing Research and Clinical Trials

Several clinical trials are currently underway to further investigate the effectiveness of Lauromacrogol 400 in various conditions:

  • Comparing different concentrations (1% vs 3%) for treating venous insufficiency[1].
  • Evaluating foam vs liquid forms for treating hemorrhoids[2].
  • Comparing Lauromacrogol 400 to other treatments for gastric varices[3][4][5][6].

These studies aim to determine the most effective and safe ways to use Lauromacrogol 400, potentially expanding its use in medical treatments.

Condition Treatment Method Key Outcomes Measured Trial Duration
Venous Insufficiency Echo-guided sclerotherapy with Lauromacrogol 400 foam Removal of truncular GSV incompetence, clinical score, quality of life 3 years
Internal Hemorrhoids Endoscopic foam sclerotherapy with Lauromacrogol Bleeding, perianal pruritus, prolapse of hemorrhoids 12 months
Gastric Varices Endoscopic injection (Lauromacrogol + Cyanoacrylate) Bleeding rate, rebleeding rate, eradication of varices 6 months to 1 year

FAQ

  • What is Lauromacrogol 400 used for in clinical trials? Lauromacrogol 400 is being studied for various conditions, including venous insufficiency, internal hemorrhoids, and gastric varices. It is used as a sclerosing agent, which means it can help close off problematic blood vessels.
  • How is Lauromacrogol 400 administered in these trials? The administration method varies depending on the condition being treated. For venous insufficiency, it's used in echo-guided sclerotherapy. For hemorrhoids, it's administered through endoscopic foam or liquid sclerotherapy. In gastric varices, it's used in combination with other agents for endoscopic injection.
  • What are the potential benefits of Lauromacrogol 400 treatment? Potential benefits include the treatment of venous insufficiency, reduction of hemorrhoid symptoms, and prevention of gastric variceal bleeding. It may offer a less invasive alternative to traditional surgical approaches for some conditions.
  • Are there any side effects or risks associated with Lauromacrogol 400? While specific side effects are not detailed in the provided trial information, patients are monitored for complications such as bleeding, pain, and other adverse events. The trials aim to assess both the efficacy and safety of the treatment.
  • How long do the clinical trials for Lauromacrogol 400 typically last? The duration of trials varies. For example, the venous insufficiency study has a follow-up period of 3 years, while some of the gastric varices studies have follow-up periods of 6 months to 1 year. The length depends on the condition being studied and the specific goals of each trial.

Ongoing Clinical Trials on Lauromacrogol 400

  • Study on Sclerotherapy for Hydrocele and Spermatocele Using Lauromacrogol 400 and Ethanol in Adult Patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

Glossary

  • Sclerotherapy: A medical procedure used to treat blood vessels or blood vessel malformations by injecting a solution directly into the vein, causing it to scar and collapse.
  • Venous Insufficiency: A condition where the veins have problems sending blood from the legs back to the heart, often resulting in blood pooling in the legs.
  • Hemorrhoids: Swollen and inflamed veins in the rectum and anus that can cause discomfort and bleeding.
  • Gastric Varices: Dilated blood vessels in or around the stomach, often a result of portal hypertension, which can lead to severe bleeding if they rupture.
  • Endoscopic: Relating to or involving the use of an endoscope, a long, thin tube with a light and camera at the end, used to look inside the body.
  • Echo-guided: A procedure guided by ultrasound imaging, which uses high-frequency sound waves to create images of structures inside the body.
  • Portal Hypertension: Increased blood pressure in the portal venous system, which can lead to various complications including gastric varices.
  • Cyanoacrylate: A fast-acting adhesive used in some medical procedures, often in combination with other agents for treating vascular conditions.

References

  1. https://clinicaltrials.gov/study/NCT00348764
  2. https://clinicaltrials.gov/study/NCT04398823
  3. https://clinicaltrials.gov/study/NCT01923064
  4. https://clinicaltrials.gov/study/NCT02468206
  5. https://clinicaltrials.gov/study/NCT02468180
  6. https://clinicaltrials.gov/study/NCT02468167